Review of the most notable advertising disputes in Life Sciences in Russia (in Russian).

• pdf, 1.15 Mb

The Q&A provides an overview of Digital Healthcare regulations applicable in Russia.

• pdf, 763.91 kb

Best Lawyers, an international legal directory annually identifying the most prominent lawyers around the world by analyzing their professional skills and achievements during the year, once again lists Lidings’ experts among the best lawyers in Russia.

Country-specific Q&A provides an overview of Pharmaceutical Advertising laws and regulations applicable in Russia.

• pdf, 3.18 Mb

August 27th, 2020 Lidings Managing Partner Andrey Zelenin and Associate Julia Kuzmenko will run a special master class dedicated to Legal Advice to Life Sciences Companies: Lawyer’s Knowledge and Capabilities as a part of the two-day educational programme of the Lomonosov Moscow State University entitled Summer Masters’ School (SMS). Becoming traditional this summer students’ event is scheduled on August 27–28 and this year will run in a Zoom format.

July 10th 2020, Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice, will take part in a 3rd Annual Conference on Compliance Enforcement in the Pharmaceutical Industry. The event is organized by MBS Agency and this year will take place in online format.

Specification of the information about the license is not required directly in the advertising of medical activities that are subject to licensing. Verification of the presence of relevant documents is carried out at the request of the advertising distributor in accordance with article 13 of the Law on advertising. The advertiser, in turn, shall provide reports, including information about the availability of a license, mandatory certification and state registration.

June 26th 2020 Julia Kuzmenko, Associate in Lidings’ Corporate and M&A practice will run an online-seminar on the legal aspects of telemedicine, organized by Sobytie conference center.

The State Duma of the Russian Federation adopted the Law¹ in the third reading which provides the opportunity to require early termination of leases for tenants affected by the deteriorating economic situation resulting from the spread of a new coronavirus infection. The final version of the Law in this part has undergone multiple fundamental changes.

This refers to the fast track registration and conduct of clinical trials, which is valid until January 1, 2021 and is worked out for medical drugs potentially effective in the fight against COVID-19.